Symvan Technology EIS Fund
The Symvan Technology EIS Fund offers investors exposure to early-stage technology businesses which are potentially disruptive in their sector and have high-growth potential.
Symvan Capital was founded in 2013 and launched the EIS fund in 2016. CEO and co-founder Kealan Doyle has worked with venture capital firms for 15 years as a corporate finance advisor and fund manager. The investment selection puts strong emphasis on management teams. Symvan collaborates with technology incubators, including Microsoft. Symvan has a particular focus on ‘post-seed’ financing, where companies have already raised early-stage funding and have now grown too large for angel investors, but are too small for lower/mid-market funds.
Four to six investments will typically be held.
These are early-stage technology businesses and by nature these firms will be more prone to failure than more mature businesses. All of the portfolio companies could fail. Diversification is limited, and this is a very concentrated portfolio of these high-risk firms.
Specific risks in this sector include failed software, patent application failure and intellectual property infringements.
Investors should also be aware these are long-term investments and are illiquid. Capital is at risk and investors should not invest money they cannot afford to lose. Tax rules can change and the value of tax benefits will depend on individual circumstances.
Fees & charges
A summary of the fees and charges is shown below. Please see the provider's documents for more details.
|Full initial charge||6%|
|Wealth Club initial saving||0%|
|Net initial charge through Wealth Club||6%|
More detail on the charges
Wealth Club aims to highlight investments we believe have merit, but you should form your own view. You should decide based on the provider's documents and ensure you have read and fully understand them before investing. This review is a marketing communication. It is not advice or a personal or research recommendation to buy the investment mentioned. It does not satisfy legal requirements promoting investment research independence and is thus not subject to prohibitions on dealing ahead of its dissemination. 22 June 2018
- Target return
- £2.85 per £1 invested
- Funds raised / sought
£4 million /
- Minimum investment